Literature DB >> 27766667

Captagon: use and trade in the Middle East.

Ahmed Al-Imam1,2, Rita Santacroce3, Andres Roman-Urrestarazu4, Robert Chilcott1, Giuseppe Bersani5, Giovanni Martinotti1,3, Ornella Corazza1,5.   

Abstract

BACKGROUND: Fenetheylline, a psychostimulant drug, often branded as Captagon, is a combination of amphetamine and theophylline. Since the cessation of its legal production in 1986, counterfeited products have been produced illicitly in south-east Europe and far-east Asia. Its profitable trade has been linked to terrorist organizations, including Islamic State of Iraq and the Levant. This study aims to reach up-to-date data, concerning the Captagon e-commerce and use in the Middle East.
METHODS: A multi-staged and multi-lingual literature search was carried out. A list of prespecified keywords was applied across medical and paramedical databases, web and Dark web, search engines, social communication media, electronic commerce websites, media networks, and the Global Public Health Intelligence Network database.
RESULTS: The use of Captagon as a stimulant in terrorist settings has been marginally covered in the literature. Data can widely be retrieved from Google and AOL search engines, YouTube, and Amazon e-commerce websites, and to a lesser extent from Alibaba and eBay. On the contrary, Middle Eastern e-commerce websites yielded almost no results. Interestingly, the Dark web generated original data for Captagon e-commerce in the Middle East.
CONCLUSION: Further investigations are needed on the role that psychoactive drugs play in terrorist attacks and civil war zones. Unless a comprehensive methodological strategy, inclusive of unconventional methods of research, is implemented, it will not be feasible to face such a threat to humanity.
Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  ISIL; NPS; amphetamine; captagon; fenethylline; terrorism

Mesh:

Substances:

Year:  2016        PMID: 27766667     DOI: 10.1002/hup.2548

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN: 0885-6222            Impact factor:   1.672


  5 in total

Review 1.  Interpol review of controlled substances 2016-2019.

Authors:  Nicole S Jones; Jeffrey H Comparin
Journal:  Forensic Sci Int Synerg       Date:  2020-05-24

2.  Reverse Triage to Increase the Hospital Surge Capacity in Disaster Response.

Authors:  Mehrdad Esmailian; Mohammad-Hossein Salehnia; Mehrdad Shirani; Farhad Heydari
Journal:  Adv J Emerg Med       Date:  2018-01-16

3.  Vaccine-driven pharmacodynamic dissection and mitigation of fenethylline psychoactivity.

Authors:  Cody J Wenthur; Bin Zhou; Kim D Janda
Journal:  Nature       Date:  2017-08-16       Impact factor: 49.962

4.  Insight of Captagon Abuse by Chemogenomics Knowledgebase-guided Systems Pharmacology Target Mapping Analyses.

Authors:  Nan Wu; Zhiwei Feng; Xibing He; William Kwon; Junmei Wang; Xiang-Qun Xie
Journal:  Sci Rep       Date:  2019-02-19       Impact factor: 4.379

5.  Lifetime prevalence of novel psychoactive substances use among adults in the USA: Sociodemographic, mental health and illicit drug use correlates. Evidence from a population-based survey 2007-2014.

Authors:  Jessica Neicun; Justin Christopher Yang; Hueyjong Shih; Pranay Nadella; Robin van Kessel; Attilio Negri; Kasia Czabanowska; Carol Brayne; Andres Roman-Urrestarazu
Journal:  PLoS One       Date:  2020-10-30       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.